There is no website visitor data available for this stock.
---
NSPR FAQ
What was InspireMD’s price range in the past 12 months?
InspireMD lowest stock price was $0.96 and its highest was $3.85 in the past 12 months.
What is InspireMD’s market cap?
Currently, no data Available
When is InspireMD’s upcoming earnings report date?
InspireMD’s upcoming earnings report date is May 14, 2024 which is in 49 days.
How were InspireMD’s earnings last quarter?
InspireMD released its earnings results on Mar 06, 2024. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.195 by $0.035.
What happened to InspireMD’s price movement after its last earnings report?
InspireMD reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.195. Following the earnings report the stock price went down -3.802%.
Which hedge fund is a major shareholder of InspireMD?
Currently, no hedge funds are holding shares in NSPR
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
Copying Ben Haynor's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +22.70% per trade.